Cost utility analysis of long-term telemonitoring of patients with DMT2: Results of the Greek pilot of the renewing health multicenter pragmatic randomized trial
Authors
Afentoula Mavrodi
Department of Business Administration, University of Macedonia, Thessaloniki, Greece
Alexandra Bargiota
Department of Endocrinology and Metabolic Diseases, Regional University Hospital of Larisa, Larisa, Greece
Haralambos Giannakakos
Regional University Hospital, 5th Regional Health Authority of Thessaly and Sterea, Larisa, Greece
Paraskevi Gkiata
Telehealth Center, Intermunicipal Digital Community of Central Greece, Trikala, Greece
Petros Pechlivangolou
Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Toronto, Canada
Georgios Koukoulis
Department of Endocrinology and Metabolic Diseases, Regional University Hospital of Larisa, Larisa, Greece
Vasilios Aletras
Department of Business Administration, University of Macedonia, Thessaloniki, Greece
DOI: https://doi.org/10.5334/ijic.1767 | Journal eISSN: 1568-4156
Language: English
Published on: Nov 1, 2014
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
© 2014 George E. Dafoulas, Afentoula Mavrodi, Alexandra Bargiota, Haralambos Giannakakos, Panagiotis Stafylas, Paraskevi Gkiata, Petros Pechlivangolou, Kyriaki Theodorou, Georgios Koukoulis, Vasilios Aletras, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.